Filing search / Ownership / Argos Therapeutics Inc

8-K

ARGS Argos Therapeutics Inc

3 May 19

Changes in Registrant's Certifying Accountant

4:10pm

8-K

ARGS Argos Therapeutics Inc

3 Dec 18

Bankruptcy or Receivership

8:01am

NT 10-Q

ARGS Argos Therapeutics Inc

14 Nov 18

Notice of late quarterly filing

2:49pm

NT 10-Q

nxlvfh 4hkea5o2m

15 Aug 18

Notice of late quarterly filing

7:00am

8-K

acd0uugzaedzs7z

20 Jul 18

Departure of Directors or Certain Officers

4:30pm

25-NSE

gefwqygbh5f4thq

19 Jul 18

Exchange delisting

9:04am

S-8

bg9tg7vfibwthxvin

15 May 18

Registration of securities for employees

5:01pm

CT ORDER

rzc9k9xcs

9 May 18

Confidential treatment order

12:25pm

8-K

qlukobqc2

24 Apr 18

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

12:00am

8-K

7g6 nxfkf

19 Apr 18

Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives

12:00am

424B5

h3qm tbp9ygfg0ht

2 Apr 18

Prospectus supplement for primary offering

12:00am

8-K

vossu2pt53usd 2u1y3

2 Apr 18

Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

12:00am

8-K

uoe6h0j svbmt2o8l

7 Mar 18

Other Events

12:00am

8-K

8qn5byql25akjfrf2o

16 Feb 18

Other Events

12:00am

8-K

q4xp pfqtm

5 Feb 18

Entry into a Material Definitive Agreement

12:00am

424B5

5i2fevanz

2 Feb 18

Prospectus supplement for primary offering

12:00am